In vitro study identifies candidate glycoside hydrolases degrading complex pyruvylated glycosaminogalactan in Luteolibacter, revealing novel pathways for bacterial glycan catabolism.
Bacterial exopolysaccharides (EPS) display extensive structural diversity arising from variation in monosaccharide composition, glycosidic linkages, and non-carbohydrate modifications. However, the enzymes responsible for degrading many EPS structures remain unknown, reflecting the limited coverage of current carbohydrate-active enzyme (CAZyme) families. Here, we investigated the microbial degradation of EPSLp, a high-molecular-mass glycosaminogalactan from Lactiplantibacillus pentosus KW1 containing the uncommon GalNAcβ1 → 2(4,6-O-R-pyruvyl)Gal motif. Enrichment cultivation with EPSLp as the main carbon source led to the isolation of Luteolibacter sp. VK1, a novel strain capable of utilizing this biopolymer. Size-exclusion chromatography and MALDI-TOF mass spectrometry showed that VK1 depolymerizes EPSLp into defined oligosaccharides, consistent with endo-acting cleavage followed by further processing. By combining genomics, AlphaFold-based structural annotation and comparative proteomics, we identified candidate CAZymes potentially involved in EPSLp catabolism. Notably, a secreted GH123 protein and a distantly related GH123-like protein were strongly associated with EPSLp-dependent growth, suggesting that this enzyme family, or related structural homologues, may contribute to extracellular EPSLp depolymerization. Together, these findings support a candidate pathway for degradation of a structurally complex, pyruvylated bacterial glycan and highlight potentially novel EPS-active enzymes whose proposed roles, predicted through bioinformatic analyses, await experimental validation.
No takes yet. Share an insight, caveat, or question.
Kietzmann et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: